Improvement of Detection Method of Pasteurella pneumotropica and Its Medical Elimination in Mice

doi:10.12300/j.issn.1674-5817.2020.197

Abstract

Abstract: Objective To modify the method for sensitive detection of Pasteurella pneumotropica in mice in routine monitoring, and to explore the feasibility of medical elimination in Pasteurella pneumotropica infected mice.Methods The Pasteurella pneumotropica were detected by routine procedure and modified method that using fluid medium before inoculation. The detection rates of the two methods were compared in statistics. The sensitivity of Pasteurella pneumotropica isolated from local facility to 12 antibiotics was studied by antimicrobial disk sensitivity test. Forty-eight female C57BL/6 mice were randomly divided into 6 groups, with 8 in each group. All the groups were set to different concentration of enrofloxacin continuously for 6 weeks to find out the safe dosage. Mice were infected with local Pasteurella pneumotropica strain, the Pasteurella pneumotropica positive mice were administered enrofloxacin in drinking water at different doses to evaluate the effect of Pasteurella pneumotropica clearance results.Results The detection rates of Pasteurella pneumotropica by routine procedure and improved method were 1.3% and 15.1%, respectively. Pasteurella pneumotropica was sensitive to enrofloxacin, cefoxitin and cefadrazole etc. The mice were safe to enrofloxacin within a daily dosage of 300 mg/kg. The Pasteurella pneumotropica was not detected from positive mice treated with 85 mg/kg enrofloxacin after 2 weeks, and kept negative after withdrawl for 6 weeks.Conclusion Using fluid medium before inoculation can improve the positive detection rate of Pasteurella pneumotropica, which is simple, convenient, and suitable for daily health monitoring of animal facility. Oral administration of enrofloxacin more than a dosage of 85 mg·kg^–1·d^–1 can elimilate Pasteurella pneumotropica from the positive mice safely and effectively, and be an alternative contingency plan for the elimination of Pasteurella pneumotropica in mice.

Key words: Pasteurella pneumotropica, Detection method improvement, Enrofloxacin, Antimicrobial susceptibility test, Medical elimination

CLC Number:

Q95-33
R-332

ZHANG Tao,CUI Can,MA Guanzhong,et al. Improvement of Detection Method of Pasteurella pneumotropica and Its Medical Elimination in Mice[J]. Laboratory Animal and Comparative Medicine, 2021, 41(4): 351-357. DOI: 10.12300/j.issn.1674-5817.2020.197.

Figures/Tables 5

References

[1] 邢进, 冯育芳, 岳秉飞, 等. 嗜肺巴斯德杆菌研究进展[J]. 中国实验动物学报, 2014, 22(2):90-94. DOI:10.3969/j.issn.1005-4847.2014.02.0020.
[2] 田克恭, 贺争鸣, 刘群. 实验动物疫病学[M]. 北京: 中国农业出版社, 2015.
[3] UENO Y, SHIMIZU R, NOZU R, et al.Elimination of Pasteurella pneumotropica from a contaminated mouse colony by oral administration of Enrofloxacin[J]. Exp Anim, 2002, 51(4):401-405. DOI:10.1538/expanim.51.401.
[4] 中华人民共和国国家质量监督检验检疫总局. 实验动物嗜肺巴斯德杆菌检测方法: GB/T 14926.12—2001[S]. 北京: 中国标准出版社, 2002.
[5] Duellet M, Cowan M, Laporte A,et al.Implementation of a PCR assay of Pasteurella pneumotropica to accurately screen for contaminated laboratory mice[J]. Lab Anim, 2011, 40(10):305-312. DOI:10.1038/laban 1011-305.
[6] 赵莹莹, 邢卉春. 基于不同引物的16S rRNA序列分析法对SBP腹水细菌的鉴定及抗感染疗效评价的意义[J]. 世界华人消化杂志, 2015, 23(29):4713-4719. DOI:10.11569/wcjd.v23.i29.4713.
[7] 王冬平, 李善如, 张敏, 等. 三种小鼠血液生理生化正常值的测定[J]. 实验动物科学与管理, 2000, 17(2):24-28. DOI:CNKI:SUN:SYDG.0.2000-02-005.
[8] FOX J G, ANDERSON L C, OTTO G M, et al.Laboratory animal medicine[M]. 3rd Ed. Amsterdam: Elsevier Inc, 2015:57-58.
[9] GOELZ M F, THIGPEN J E, MAHLER J, et al.Efficacy of various therapeutic regimens in eliminating Pasteurella pneumotropica from the mouse[J]. Lab Anim Sci, 1996, 46(3):280-285.
[10] MATSUMIYA L C, LAVOIE C.An outbreak of Pasteurella pneumotropica in genetically modified mice: treatment and elimination[J]. Contemp Top Lab Anim Sci, 2003, 42(2):26-28.
[11] 李红, 刘星, 张丽芳, 等. 嗜肺巴斯德杆菌选择性培养基研制及应用[J]. 中国实验动物学报, 2001, 9(1):20-25. DOI:10.3969/j.issn.1005-4847.2001.01.004.
[12] 高正琴, 邢进, 王春玲, 等. 小鼠嗜肺巴氏杆菌感染的监测与分析[J]. 实验动物与比较医学, 2007, 27(3):183-185. DOI:10.3969/j.issn.1674-5817.2007.03.009.
[13] 赵晶, 康世良. 兽用喹诺酮类抗菌剂恩诺沙星的药物代谢动力学研究进展[J]. 黑龙江畜牧兽医, 1999(4):40-41. DOI:CNKI:SUN:HLJX.0.1999-04-038.
[14] 董漓波, 叶启薇, 孙永学, 等. 恩诺沙星对SD系大白鼠的急性及亚急性毒性研究[J]. 华南农业大学学报, 1995, 16(4):1-4. DOI:CNKI:SUN:HNNB.0.1995-04-000.

[1]	ZHANG Jiaoling, LIN Aping, XU Shiying, PAN Dequan, CAI Yijun. Optimization and Application of Mouse Embryo Transfer Technology [J]. Laboratory Animal and Comparative Medicine, 2026, (): 1-9.
[2]	. [J]. Laboratory Animal and Comparative Medicine, 2026, 46(4): 611-613.
[3]	LI Chunyang, LIU Xingchen, LI Yuzhuo, LU Yong, WANG Yan, GAO Changshan, NIE Yanhong, BIAN Xinyan, HU Chao, ZHU Jiaqiao, SUN Qiang. Generation of Cynomolgus and Rhesus Monkey Models Carrying the BMPR1B^FecB Variant [J]. Laboratory Animal and Comparative Medicine, 2026, 46(4): 467-475.
[4]	LI Hongman, CHEN Yutong, SHI Yingpei, WANG Yijing, PAN Yan, XU Tong, ZHOU Yi, DENG Qiyue, LIU Xue. A New Perspective on Mental Health Assessment in Laboratory Animals: Stress Response Monitoring Based on Hair Characteristics [J]. Laboratory Animal and Comparative Medicine, 2026, 46(4): 553-563.
[5]	MA Wenjing, LIU Yanping, LI Yifan, GUO Huan, XIE Lihui, DU Longji, MA Jiali, WANG Hongping, LI Jiamin. Practice in Validity Period Management of Disinfectants, Feed, and Bedding in Laboratory Animal Facilities under Good Laboratory Practice Management System [J]. Laboratory Animal and Comparative Medicine, 2026, 46(4): 593-603.
[6]	LI Zifa, LIU Shan, SUN Wei, ZHAO Feng, WEI Sheng, LI Qin, XU Kaiyong. Reflections on Building a Science-Education Integration System for Laboratory Animal Science: A Case Study of Shandong University of Traditional Chinese Medicine [J]. Laboratory Animal and Comparative Medicine, 2026, 46(4): 604-610.
[7]	QIANG Sujing, LI Dongting, XU Jinhua, CAI Li, WEI Siyu, ZOU Jialei, DING Yuqiang. Identification and Analysis of the Klebsiella pneumoniae Species Complex in Laboratory Rats and Mice [J]. Laboratory Animal and Comparative Medicine, 2026, 46(4): 564-572.
[8]	LEI Jianjun, SUO Chenhao, ZHANG He. Resveratrol Alleviates Blood‑Brain Barrier Damage in Cerebral Ischemia‑Reperfusion Rat Models through Modulation of the CCL3/CCR5 Signaling Pathway [J]. Laboratory Animal and Comparative Medicine, 2026, 46(4): 487-497.
[9]	WANG Lu, WANG Qingjie, YANG Chunhong, ZHANG Yijian. Application of New Approach Methodologies in Biomedical Field and Their Implementation of "3R" Principle [J]. Laboratory Animal and Comparative Medicine, 2026, 46(4): 573-582.
[10]	GONG Zhiqun, RAO Xiwu, ZHANG Tianyi, WU Rongchen, YE Mingnan, JIANG Chunxi, WANG Sumei, ZHU Yanjuan, CHAI Xiaoshu. Construction and Evaluation of Mouse Models Simulating Immune Checkpoint Inhibitor-Associated Pneumonitis [J]. Laboratory Animal and Comparative Medicine, 2026, 46(4): 498-506.
[11]	LIU Liang, CHEN Bin, MEN Li, ZHANG Huan, LIU Jinzhou, LIU Keliang, LI Yangyou, DUAN Jiahui, YAN Jintai, YANG Guolin, JIN Bo. Serving National Strategies and the Chengdu-Chongqing Biomedical Industry: Innovative Layout and Practical Pathways of Undergraduate Education in Laboratory Animal Science [J]. Laboratory Animal and Comparative Medicine, 2026, (): 1-12.
[12]	YANG Ran, FENG Jiwei, MA Fei, ZHANG Yu, LIU Zhiwei, JIIN Lilun. Fraxetin Inhibits Ferroptosis and Alleviates Cartilage Damage in Osteoarthritis Rat Through Nrf2/HO-1 Signaling Pathway [J]. Laboratory Animal and Comparative Medicine, 2026, (): 1-12.
[13]	AI Xiufeng, ZHANG Lizong, FANG Mingsun, LÜ Dongying, CHEN Chu, CAI Zhaowei, WANG Dejun. Analysis of Differences in the Intestinal Flora of Rats and Mice after Drinking Chlorinated Water Based on 16S rRNA Sequencing [J]. Laboratory Animal and Comparative Medicine, 2026, 46(3): 437-445.
[14]	ZHOU Yimin, ZHANG Xinyu, YANG Jianuo, LIU Mengjia, SI Cancan, YE Hailü, SUN Wenchao, LAN Tian. Development of a Triplex TaqMan Quantitative PCR Method for Simultaneous Detection of MHV, MPV, and Reo-3 [J]. Laboratory Animal and Comparative Medicine, 2026, 46(3): 408-415.
[15]	. [J]. Laboratory Animal and Comparative Medicine, 2026, 46(3): 464-466.